India Pharma Outlook Team | Monday, 05 October 2026
An inspection by the Uttar Pradesh Food Safety and Drug Administration (UPFSDA) reveals hospitals sell medicines at prices far above their own purchase costs.
Officials inspected 214 hospital pharmacies across medical colleges and private facilities.
They analyzed 130 medicines and found 36 with maximum retail prices more than 10 times the purchase price.
In extreme cases, the gap reaches 67 times. These differences appear most sharply in injectable drugs used in ICUs and for serious infections.
The findings raise direct questions about how such mark-ups enter patient bills and whether any real discounts ever reach families.
UPFSDA teams collected purchase price and MRP data from hospital pharmacies. The numbers show clear and repeated disparities.
Key examples include:
Most of these drugs treat critically ill patients in intensive care or fight severe bacterial and fungal infections. The regulator also checked medical devices and found substantial gaps between procurement costs and printed MRPs in several cases.
Also Read: Counterfeit Drugs in India: How Packaging Gaps Hurt Supply Chain
Hospitals procure medicines at far lower rates yet list them at the full MRP on packs. Officials note that a high printed MRP can create room for discounts while still leaving a large gap between actual cost and the final billed amount.
They now examine whether this pricing structure ultimately benefits patients or simply widens the margin for hospitals and pharmacies.
The department continues inspections of hospital pharmacies to check quality, availability, and pricing of both medicines and devices. Officials plan to use the collected data to identify specific cases that need further scrutiny and possible action.
UPFSDA officials state they are studying the reasons behind these wide variations. They are looking at the overall pricing and trade margin structure that allows such large differences.
The central question they raise is: does the high MRP ever translate into meaningful discounts for patients, or does the gap stay largely intact inside treatment packages?
The inspection covers both government medical-college pharmacies and private hospital outlets. The findings so far show the same pattern of elevated mark-ups across the board. Further data collection will decide which cases move to deeper investigation.
These price gaps directly affect the final amount that appears on hospital bills. Families and the public system both feel the impact when critical medicines carry mark-ups of 10 to 67 times the procurement cost. The regulator’s ongoing work will determine how far the system allows such differences to continue.
.jpg)
